What You Should Know
Axoft has raised an oversubscribed $55M Series A led by C.P. Group Innovation, bringing its total funding to over $60M.The capital will be used to expand global clinical trials, progress U.S. regulatory approval for its implantable Brain-Computer Interfaces (iBCIs), and build a GMP manufacturing facility in Cambridge, MA.Axoft’s iBCIs utilize a proprietary material called Fleuron™, which is 10,000x softer than traditional polyimide, significantly reducing tissue scarring
Read More
Nordic 2026 Survey: Epic Managed Services Transition from Staffing Support to Strategic IT Operating Model
What You Should Know
Nordic Global has released 2026 survey findings showing that 61% of healthcare IT leaders now view Application Managed Services (AMS) as a central, rather than supplemental, part of their IT strategy.The market is seeing a distinct urban-rural divide: 70% of urban organizations view AMS as a strategic lever for transformation, compared to 43% of rural organizations who use it primarily for operational resilience.Urban and large health systems are increasingly using AMS to
Read More
Operationalizing Precision Medicine 2026: U.S. Health Systems Scale Genetic Testing and AI Integration
What You Should Know
Precision medicine has transitioned from "one-off" testing to organized institutional programs at more than three-quarters of surveyed U.S. health systems, according to new research from the Center for Connected Medicine (CCM) at UPMC.This represents a massive shift from 2020, when 69% of organizations had little to no precision medicine deployment.While adoption is high, reimbursement uncertainty, high costs, and operational complexity remain the primary barriers to
Read More
CareDx to Acquire Naveris for $160M to Expand into HPV-Driven Cancer MRD Monitoring
What You Should Know
CareDx has entered into a definitive agreement to acquire Naveris, a precision oncology company specializing in blood-based monitoring for viral-mediated cancers.The deal includes $160M in up-front cash, with potential for an additional $100M based on future revenue milestones.Naveris’ flagship platform utilizes Tumor Tissue Modified Viral (TTMV®) DNA to detect and monitor HPV-driven cancers with high accuracy.The acquisition is expected to close in the third quarter of
Read More
Rad AI Appoints David Leonard as COO and Elizabeth Bergey, MD, as First Chief Clinical Officer
What You Should Know
Rad AI has appointed David Leonard as Chief Operating Officer (COO) and Elizabeth Bergey, MD, as the company’s first Chief Clinical Officer (CCO).Leonard, previously Head of Operations, Strategy, and Investor Relations, will focus on scaling internal infrastructure and enhancing go-to-market strategies for AI-enabled reporting.Dr. Bergey, a board-certified radiologist and former CEO of Quantum Radiology, transitions from Chief Medical Innovation Officer to lead clinical
Read More
Moderna Deploys Salesforce Agentforce Life Sciences to Unify Global Commercial Operations
What You Should Know
Moderna has selected Salesforce’s Agentforce Life Sciences to serve as its unified, global platform for commercial operations and customer engagement.The platform will consolidate data from SAP, ecommerce, and regional systems to create a single "Customer 360" source of truth for all healthcare provider (HCP) interactions.Field teams will utilize AI-powered agents to automate cycle planning, deliver "next best action" recommendations, and streamline real-time call
Read More
FDA Announces Real-Time Clinical Trial Pilot Program and Proof-of-Concept Studies with AstraZeneca and Amgen
What You Should Know
The FDA has launched two proof-of-concept (PoC) real-time clinical trials (RTCT) that report endpoints and data signals to the agency as they occur.AstraZeneca is leading a Phase 2 trial (TRAVERSE) for mantle cell lymphoma, while Amgen is conducting a Phase 1b trial (STREAM-SCLC) for small cell lung carcinoma.The initiative aims to eliminate the traditional "hiatus" between clinical phases, moving toward a model of "continuous" trials that reduces regulatory lag.A Request
Read More
Beth Israel Lahey Health Partners with Heidi to Deploy Ambient AI Scribing to All Physicians
What You Should Know
Beth Israel Lahey Health (BILH) is expanding its partnership with Heidi to provide ambient AI scribing capabilities to all of its more than 6,000 providers.An initial 6-month trial involving 1,000 providers resulted in 89% satisfaction regarding the quality of generated medical notes.The technology significantly impacts clinician well-being, with 82% of trial users reporting reduced cognitive load and 74% noting a reduction in time spent working outside of standard
Read More
Koda Health Secures Investment from UPMC Enterprises for AI-Enhanced Advance Care Planning Platform
What You Should Know
The Investment: Koda Health secured a Series A strategic investment from UPMC Enterprises to aggressively scale its AI-enhanced Advance Care Planning (ACP) platform across complex patient populations.The Financial Toll: The American healthcare system currently spends an estimated $200 billion annually on care that patients would not have wanted had they been engaged in care planning earlier in their journey.The Technology Engine: The platform navigates patients through
Read More
Covera Health and Medmo Combine to Launch Nationwide AI Diagnostic Imaging and Care Coordination Platform
What You Should Know
Covera Health and Medmo have officially merged into a single organization, creating a unified platform that manages diagnostic imaging for nearly 6 million Americans.The combined entity is backed by additional capital from Insight Partners and serves major clients, including Walmart, Blue Cross Blue Shield of Michigan, and three of the five largest national health plans.Covera’s AI-driven platform focus on diagnostic accuracy has produced up to 12 percent lower downstream
Read More
